Pharmaceutical companies are starting to design clinical trials for cancer treatments using data on cancer genetics to pinpoint which patients are more likely to respond to each drug, according to MIT's Technology Review. Emily Singer writes that doctors are hoping to be able to treat patients with specific drugs according to the genetic profile of their illness, and which mutations are affecting their individual tumors.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

York University researchers find genomic evidence of inbreeding in the yellow-banded bumblebee, according to Reuters.

In its survey of US adults, the Pew Research Center finds that views on the genetic engineering of animals depend on why it's done.

The Scientist reports agricultural researchers are working on a gene-stacking tool.

In Nature this week: statistical method for overcoming case-control imbalance issues, and more.